Email ID
Password
Scrip   
Cervarix, Prevenar and Januvia among new Japanese approvals
19 October 2009
Ian Haydock

GlaxoSmithKline's Cervarix has become the first cervical cancer vaccine to be approved in Japan, following a formal regulatory clearance from the country's ministry of health, labour and welfare.

Wyeth/ Pfizer's paediatric pneumococcal conjugate vaccine Prevenar and Merck & Co's...



Please Login to read the full article.
JOB OF THE WEEK Promote your vacancy here
© 2010 Informa plc. All rights reserved.
This site is owned and operated by Informa plc ("Informa") whose registered office is Mortimer House, 37-41 Mortimer Street, London, W1T 3JH. Registered in England and Wales. Number 3099067. UK VAT Group: GB 365 4626 36